Enhanced expression of PAI–1 in visceral fat: Possible contributor to vascular disease in obeisty

Author:  ["Iichiro Shimomura","Tohru Funahasm","Masahiko Takahashi","Kazuhisa Maeda","Kazuaki Kotani","Tadashi Nakamura","Shizuya Yamashita","Masakazu Miura","Yoji Fukuda","Kaoru Takemura","Katsuto Tokunaga","Yuji Matsuzawa"]

Publication:  Nature Medicine

CITE.CC academic search helps you expand the influence of your papers.

Tags:     Medicine

Abstract

The presence of obesity increases the risk of thrombotic vascular diseases. The role of fat accumulation and its effect on plasminogen activator inhibitor–1 (PAI–1) levels was investigated in humans and animals. Plasma PAI–1 levels were closely correlated with visceral fat area but not with subcutaneous fat area in human subjects. PAI–1 mRNA was detected in both types of fat tissue in obese rats but increased only in visceral fat during the development of obesity. These data suggest that an enhanced expression of the PAI–1 gene in visceral fat may increase plasma levels and may have a role in the development of vascular disease in visceral obesity.

Cite this article

Shimomura, I., Funahasm, T., Takahashi, M. et al. Enhanced expression of PAI–1 in visceral fat: Possible contributor to vascular disease in obeisty. Nat Med 2, 800–803 (1996). https://doi.org/10.1038/nm0796-800

View full text

>> Full Text:   Enhanced expression of PAI–1 in visceral fat: Possible contributor to vascular disease in obeisty

A month–long effect from a single injection of microencapsulated human growth hormone

Bradykinin–evoked sensitization of airway sensory nerves: A mechanism for ACE–inhibitor cough